Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Knowledge gaps and research recommendations for essential tremor.

Hopfner F, Haubenberger D, Galpern WR, Gwinn K, Van't Veer A, White S, Bhatia K, Adler CH, Eidelberg D, Ondo W, Stebbins GT, Tanner CM, Helmich RC, Lenz FA, Sillitoe RV, Vaillancourt D, Vitek JL, Louis ED, Shill HA, Frosch MP, Foroud T, Kuhlenbäumer G, Singleton A, Testa CM, Hallett M, Elble R, Deuschl G.

Parkinsonism Relat Disord. 2016 Dec;33:27-35. doi: 10.1016/j.parkreldis.2016.10.002. Epub 2016 Oct 4. Review.

PMID:
27769649
2.

Essential Tremor: What We Can Learn from Current Pharmacotherapy.

Ondo W.

Tremor Other Hyperkinet Mov (N Y). 2016 Mar 4;6:356. doi: 10.7916/D8K35TC3. eCollection 2016 Mar 4. Review.

3.

Isolated vocal tremor as a focal phenotype of essential tremor: a retrospective case review.

Patel A, Frucht SJ.

J Clin Mov Disord. 2015 Mar 2;2:4. doi: 10.1186/s40734-015-0016-5. eCollection 2015 Mar 2.

4.

Efficacy and Safety of Topiramate for Essential Tremor: A Meta-Analysis of Randomized Controlled Trials.

Chang KH, Wang SH, Chi CC.

Medicine (Baltimore). 2015 Oct;94(43):e1809. doi: 10.1097/MD.0000000000001809.

5.

SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy.

Bergareche A, Bednarz M, Sánchez E, Krebs CE, Ruiz-Martinez J, De La Riva P, Makarov V, Gorostidi A, Jurkat-Rott K, Marti-Masso JF, Paisán-Ruiz C.

Hum Mol Genet. 2015 Dec 15;24(24):7111-20. doi: 10.1093/hmg/ddv410. Epub 2015 Oct 1.

6.

Hcn1 is a tremorgenic genetic component in a rat model of essential tremor.

Ohno Y, Shimizu S, Tatara A, Imaoku T, Ishii T, Sasa M, Serikawa T, Kuramoto T.

PLoS One. 2015 May 13;10(5):e0123529. doi: 10.1371/journal.pone.0123529. eCollection 2015 May 13.

7.

Homozygous SLC6A17 mutations cause autosomal-recessive intellectual disability with progressive tremor, speech impairment, and behavioral problems.

Iqbal Z, Willemsen MH, Papon MA, Musante L, Benevento M, Hu H, Venselaar H, Wissink-Lindhout WM, Vulto-van Silfhout AT, Vissers LE, de Brouwer AP, Marouillat S, Wienker TF, Ropers HH, Kahrizi K, Nadif Kasri N, Najmabadi H, Laumonnier F, Kleefstra T, van Bokhoven H.

Am J Hum Genet. 2015 Mar 5;96(3):386-96. doi: 10.1016/j.ajhg.2015.01.010. Epub 2015 Feb 19.

8.

Heterogeneity of tremor mechanisms assessed by tremor-related cortical potential in mice.

Park YG, Choi JH, Lee C, Kim S, Kim Y, Chang KY, Paek SH, Kim D.

Mol Brain. 2015 Jan 15;8:3. doi: 10.1186/s13041-015-0093-2.

9.

The GABA Hypothesis in Essential Tremor: Lights and Shadows.

Gironell A.

Tremor Other Hyperkinet Mov (N Y). 2014 Jul 16;4:254. doi: 10.7916/D8SF2T9C. eCollection 2014 Jul 16.

10.

Neuroimaging essentials in essential tremor: a systematic review.

Sharifi S, Nederveen AJ, Booij J, van Rootselaar AF.

Neuroimage Clin. 2014 May 9;5:217-31. doi: 10.1016/j.nicl.2014.05.003. eCollection 2014 May 9. Review.

11.

Treatment of essential tremor with long-chain alcohols: still experimental or ready for prime time?

Haubenberger D, Nahab FB, Voller B, Hallett M.

Tremor Other Hyperkinet Mov (N Y). 2014 Feb 5;4. pii: tre-04-211-4673-2. doi: 10.7916/D8RX991R. eCollection 2014 Feb 5.

12.

The potential roles of T-type Ca2+ channels in motor coordination.

Park YG, Kim J, Kim D.

Front Neural Circuits. 2013 Oct 28;7:172. doi: 10.3389/fncir.2013.00172. eCollection 2013 Oct 28. Review.

13.

Key issues in essential tremor genetics research: Where are we now and how can we move forward?

Testa CM.

Tremor Other Hyperkinet Mov (N Y). 2013;3. pii: tre-03-105-1843-1. doi: 10.7916/D8Q23Z0Z. Epub 2013 Jan 22.

14.

Ethanol activation of protein kinase A regulates GABAA α1 receptor function and trafficking in cultured cerebral cortical neurons.

Carlson SL, Kumar S, Werner DF, Comerford CE, Morrow AL.

J Pharmacol Exp Ther. 2013 May;345(2):317-25. doi: 10.1124/jpet.112.201954. Epub 2013 Feb 13.

15.

Substance of abuse and movement disorders: complex interactions and comorbidities.

Deik A, Saunders-Pullman R, Luciano MS.

Curr Drug Abuse Rev. 2012 Sep;5(3):243-53. Review.

16.

Use of antiepileptic drugs for hyperkinetic movement disorders.

Siniscalchi A, Gallelli L, De Sarro G.

Curr Neuropharmacol. 2010 Dec;8(4):359-66. doi: 10.2174/157015910793358187.

17.

Comparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor.

Quesada A, Bui PH, Homanics GE, Hankinson O, Handforth A.

Eur J Pharmacol. 2011 May 20;659(1):30-6. doi: 10.1016/j.ejphar.2011.01.004. Epub 2011 Jan 21.

18.

T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor.

Handforth A, Homanics GE, Covey DF, Krishnan K, Lee JY, Sakimura K, Martin FC, Quesada A.

Neuropharmacology. 2010 Nov;59(6):380-7. doi: 10.1016/j.neuropharm.2010.05.012. Epub 2010 Jun 12.

19.

Ethanol reduces GABAA alpha1 subunit receptor surface expression by a protein kinase Cgamma-dependent mechanism in cultured cerebral cortical neurons.

Kumar S, Suryanarayanan A, Boyd KN, Comerford CE, Lai MA, Ren Q, Morrow AL.

Mol Pharmacol. 2010 May;77(5):793-803. doi: 10.1124/mol.109.063016. Epub 2010 Feb 16.

20.

Modifications of antiepileptic drugs for improved tolerability and efficacy.

Landmark CJ, Johannessen SI.

Perspect Medicin Chem. 2008 Feb 14;2:21-39.

Supplemental Content

Support Center